Raymond James Financial
EDIT icon

Raymond James Financial’s Editas Medicine EDIT Stock Holding History

Raymond James Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Buy
1,318,947
+25,099
+2% +$73.4K ﹤0.01% 2866
2026
Q1 		$3.2M Buy
1,293,848
+109,178
+9% +$231K ﹤0.01% 2961
2025
Q4 		$2.43M Buy
1,184,670
+1,020,782
+623% +$2.95M ﹤0.01% 3104
2025
Q3 		$569K Sell
163,888
-18,230
-10% -$50.9K ﹤0.01% 4031
2025
Q2 		$401K Sell
182,118
-15,348
-8% -$25.1K ﹤0.01% 4134
2025
Q1 		$229K Sell
197,466
-41,501
-17% -$61K ﹤0.01% 4346
2024
Q4 		$303K Buy
+238,967
New +$609K ﹤0.01% 4178

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Raymond James Financial's EDIT Position: Q2 2026 in Review

Raymond James Financial increased its Editas Medicine (EDIT) stake by 1.9% in Q2 2026, buying an estimated $73.4K and bringing the position to 1,318,947 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

Raymond James Financial first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Raymond James Financial held 1,318,947 shares of Editas Medicine worth $4.27M as of Q2 2026.
  • Raymond James Financial bought 25,099 Editas Medicine shares in Q2 2026, an estimated $73.4K.
  • Editas Medicine made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2866 holding.
  • Raymond James Financial first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.